2,366 results match your criteria: "Center for AIDS Research.[Affiliation]"
bioRxiv
November 2024
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037 USA.
Numerous proteins perform their functions by transitioning between various structures. Understanding the conformational ensembles associated with these states is essential for uncovering crucial mechanistic aspects that regulate protein function. In this study, we utilized AlphaFold3 () to investigate the structural dynamics and mechanisms of enzymes involved in DNA homeostasis, using NAD-dependent Taq ligases and human DNA Ligase 1 as a case example.
View Article and Find Full Text PDFbioRxiv
October 2024
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037 USA.
Existing antibody language models () are pre-trained using a masked language modeling () objective with uniform masking probabilities. While these models excel at predicting germline residues, they often struggle with mutated and non-templated residues, which are crucial for antigen-binding specificity and concentrate in the complementarity-determining regions (). Here, we demonstrate that preferential masking of the non-templated CDR3 is a compute-efficient strategy to enhance model performance.
View Article and Find Full Text PDFAIDS Behav
November 2024
Medical Practice Evaluation Center, Massachusetts General Hospital, 100 Cambridge Street, 16th Floor, Boston, MA, 02114, USA.
South Africa's Central Chronic Medicine Dispensing and Distribution (CCMDD) program provides community-based medication delivery for clinically stable people with HIV (PWH) on antiretroviral therapy (ART). To evaluate CCMDD implementation, we conducted semi-structured interviews with 60 PWH enrolled in CCMDD for at least 12 months. In a directed content analysis based on the Practical, Robust Implementation and Sustainability Model (PRISM) implementation science framework, key themes were compared with qualitative data collected from PWH enrolling in CCMDD at an earlier time-point.
View Article and Find Full Text PDFDrug Alcohol Depend Rep
December 2024
Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA.
Background: Indigenous communities in the United States experience disproportionate rates of overdose morbidity and mortality due to a range of historical traumas and ongoing oppression. Limited health and harm reduction service access on some Tribal lands exacerbate these challenges. To date, little is known about naloxone access on tribal reservation lands.
View Article and Find Full Text PDFGlob Health Med
October 2024
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Since the world's first case series of human immunodeficiency virus (HIV) infection were reported, more than 40 decades have passed. The advancement of HIV treatment and prevention has progressed drastically. Especially, the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention has been proven by a number of trials and the number of new HIV cases has declined over the years due to the large-scale and rapid implementation of PrEP and universal HIV treatment in multiple countries.
View Article and Find Full Text PDFSci Rep
October 2024
Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
In this work our aim was to identify early biomarkers in plasma samples associated with mortality in children with perinatal HIV treated early in life, to potentially inform early intervention targeting this vulnerable group. 20/215 children (9.3%) with perinatal HIV, enrolled within 3 months of age died prematurely within the first year of the study, despite early ART initiation.
View Article and Find Full Text PDFBiomedicines
October 2024
Center for Environmental/Occupational Risk Analysis & Management, University of South Florida College of Public Health, Tampa, FL 33612, USA.
J Immunol Methods
November 2024
Duke Research and Discovery at Research Triangle Park, 27 Alexandria Way, Durham, NC, USA. Electronic address:
The NIAID DAIDS-sponsored External Quality Assurance Program Oversight Laboratory (EQAPOL) manages an interferon-gamma (IFN-γ) enzyme-linked immunospot (ELISpot) external proficiency program. The ELISpot program evaluates the accuracy and variability of results across laboratories. The variability in the program is quantified via the dispersion, which is the ratio of the variance over the mean of the background-corrected spot-forming cells (SFC) replicates obtained under stimulation with different peptide pools (CMV, CEF).
View Article and Find Full Text PDFJ Acquir Immune Defic Syndr
November 2024
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
J Control Release
December 2024
NHC Key Laboratory of Human Disease Comparative Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. Electronic address:
Sci Adv
October 2024
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
c-di-GAMP was first identified in bacteria to promote colonization, while mammalian 2'3'-cGAMP is synthesized by cGAS to activate STING for innate immune stimulation. However, 2'3'-cGAMP function beyond innate immunity remains elusive. Here, we report that 2'3'-cGAMP promotes cell migration independent of innate immunity.
View Article and Find Full Text PDFEClinicalMedicine
July 2024
Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain.
medRxiv
September 2024
Department of Public Health, Environments and Society, London School of Hygiene and Topical Medicine (LSHTM), London, UK.
medRxiv
September 2024
Università degli studi di Cassino e del Lazio Meridionale (UNICAS), Department of Civil and Mechanical Engineering, Cassino, Italy.
Drug Alcohol Depend
November 2024
Duke University School of Nursing, 307 Trent Drive, Durham, NC 27710; Duke Global Health Institute, 310 Trent Drive, Durham, NC 27710, USA; Duke Center for Global Mental Health, 310 Trent Drive, Durham, NC 27710, USA. Electronic address:
Background: Medications for opioid use disorder (MOUD) are a crucial intervention for pregnant and postpartum individuals with opioid use disorder (OUD). However, there is paucity of data on the factors associated with MOUD treatment success in this population. This scoping review aimed to evaluate factors associated with MOUD success during the pregnancy and postpartum period.
View Article and Find Full Text PDFVaccines (Basel)
September 2024
Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430071, China.
The development of effective vaccines against infectious diseases remains a critical challenge in global health. Animal models play a crucial role in vaccine development by providing valuable insights into the efficacy, safety, and mechanisms of immune response induction, which guide the design and formulation of vaccines. However, traditional animal models often inadequately recapitulate human immune responses.
View Article and Find Full Text PDFViruses
September 2024
Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
PLoS Pathog
September 2024
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
J Racial Ethn Health Disparities
September 2024
Center for Epidemiologic Research, Department of Epidemiology, School of Public Health, Brown University, Box G-S121-2, 121 South Main Street, Providence, RI, USA.
AIDS Res Hum Retroviruses
September 2024
Department of Medicine, Division of Infectious Diseases and HIV Medicine, Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, Ohio, USA.
People with human immunodeficiency virus (PWH), despite achieving viral suppression through antiretroviral therapy, face increased risk and earlier onset of atherosclerotic cardiovascular diseases than the general population. CD57+ T cells can be readily recovered from atherosclerotic plaques and likely contribute to disease by targeting endothelial cells (ECs); however, the specific mechanisms facilitating the infiltration of these cells into plaques remain elusive. Here, we report the development of a novel assay to quantify T cell adhesion to and transmigration through a primary human vascular EC monolayer and show that CD57+ T cells preferentially adhere to and transmigrate through the monolayer.
View Article and Find Full Text PDFBrief Bioinform
July 2024
Department of Pharmaceutical Sciences, Computational Chemical Genomics Screening Center, Pharmacometrics & System Pharmacology PharmacoAnalytics, School of Pharmacy, University of Pittsburgh, 335 Sutherland Drive, Pittsburgh, PA 15261, United States.
Therapeutic antibody design has garnered widespread attention, highlighting its interdisciplinary importance. Advancements in technology emphasize the critical role of designing nanobodies and humanized antibodies in antibody engineering. However, current experimental methods are costly and time-consuming.
View Article and Find Full Text PDFJ Int Assoc Provid AIDS Care
September 2024
Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Background: Early initiation of antiretroviral therapy improves human immunodeficiency virus (HIV) outcomes. However, achieving earlier treatment initiation is challenging for many reasons including provider awareness and clinic barriers; this study sought to understand perceptions of an early initiation program.
Methods: We interviewed 10 providers from 3 HIV clinics in North Carolina (October-November 2020).
AIDS Behav
December 2024
Department of Psychiatry & Behavioral Sciences, Montefiore Medical Center, Bronx, NY, USA.
Older women with HIV face challenges to their quality of life, including neurocognitive decline, early-onset menopause, and chronic health issues. Chief among these concerns is depression, the most common psychiatric comorbidity among people living with HIV, with rates twice as high among women as men. However, tailored interventions among older women living with HIV and depression are lacking.
View Article and Find Full Text PDFJ Med Virol
September 2024
Division of Pathology and Laboratory Medicine, Children's National Hospital, Washington, DC, USA.
Sci Immunol
August 2024
Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
Adolescents are a growing population of people living with HIV. The period between weaning and sexual debut presents a low-risk window for HIV acquisition, making early childhood an ideal time for implementing an immunization regimen. Because the elicitation of broadly neutralizing antibodies (bnAbs) is critical for an effective HIV vaccine, our goal was to assess the ability of a bnAb B cell lineage-designed HIV envelope SOSIP (protein stabilized by a disulfide bond between gp120-gp41-named "SOS"-and an isoleucine-to-proline point mutation-named "IP"-at residue 559) to induce precursor CD4 binding site (CD4bs)-targeting bnAbs in early life.
View Article and Find Full Text PDF